ArticleJournal of the National Cancer Center2024

Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial.

Rong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.